← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2016Last known activity
Sep 20, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT04855513CollaboratorN/ASep 20, 2021
- NCT04855513Study directorN/ASep 20, 2021
- NCT03548766CollaboratorPhase 3Oct 31, 2018
- NCT03548766Overall official - principal investigatorPhase 3Oct 31, 2018
- NCT02879409CollaboratorN/ANov 1, 2016
Details
- Last known activity
- Sep 20, 2021